Leerink Pharmaceutical Fund LP is a hedge fund based in Boston, Massachusetts. According to its most recent Form D, filed Dec 6, 2017, the fund has sold $83,501,000 of interests to 11 investors since its first sale in Jul 2014. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include GP LP Leerink Pharmaceutical Fund.
Performance
No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $83,501,000Cumulative sales reported on Form D
- Investors
- 11
- First sale
- Jul 1, 2014
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- GP LP Leerink Pharmaceutical Fund
- Latest Form D
- Dec 6, 2017
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Dec 6, 2017 | Form D/A (amendment) | $83,501,000 | 11 | SEC.gov ↗ |
| Jun 23, 2017 | Form D/A (amendment) | $83,501,000 | 11 | SEC.gov ↗ |
| Jun 24, 2016 | Form D/A (amendment) | $83,501,000 | 7 | SEC.gov ↗ |
| Jun 26, 2015 | Form D/A (amendment) | $45,501,000 | 3 | SEC.gov ↗ |
| Jun 27, 2014 | Form D | $0 | 0 | SEC.gov ↗ |
5 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jun 27, 2014. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about Leerink Pharmaceutical Fund LP
What is the minimum investment for Leerink Pharmaceutical Fund LP?
Leerink Pharmaceutical Fund LP's latest Form D, filed Dec 6, 2017, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Leerink Pharmaceutical Fund LP?
Leerink Pharmaceutical Fund LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Leerink Pharmaceutical Fund LP raised?
Leerink Pharmaceutical Fund LP reports $83,501,000 sold from 11 investors on its Form D filed Dec 6, 2017. This is cumulative sales since the offering began, not current assets or performance.
Where is Leerink Pharmaceutical Fund LP based?
Leerink Pharmaceutical Fund LP is based in Boston, Massachusetts.
When did Leerink Pharmaceutical Fund LP launch?
Leerink Pharmaceutical Fund LP reports its first sale in Jul 2014.
Size compared with every hedge fund
Raised more than 43% of the 475 hedge funds based in Massachusetts, and more than 55% of all 10,141 that report sales.